NasdaqGS:INVAPharmaceuticals
Why Innoviva (INVA) Is Up 5.7% After Reporting a Return to Profitability in Q2
Innoviva, Inc. recently announced its second quarter and six-month results for 2025, reporting revenue of US$100.28 million for the quarter and turning a net income of US$63.69 million from a net loss a year earlier.
This dramatic shift to profitability was also reflected in improved earnings per share, highlighting a substantial turnaround in the company's financial performance year-over-year.
We'll explore how Innoviva's move from loss to profitability in the latest quarter reshapes its...